Diverse antiepileptic drugs increase the ratio of background synaptic inhibition to excitation and decrease neuronal excitability in neurones of the rat entorhinal cortex in vitro  by Greenhill, S.D. & Jones, R.S.G.
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dIVERSE ANTIEPILEPTIC DRUGS INCREASE THE RATIO OF
ACKGROUND SYNAPTIC INHIBITION TO EXCITATION AND
ECREASE NEURONAL EXCITABILITY IN NEURONES OF
HE RAT ENTORHINAL CORTEX IN VITRO
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e. D. GREENHILL AND R. S. G. JONES*
epartment of Pharmacy and Pharmacology, University of Bath, Cla-
erton Down, Bath, BA2 7AY, UK
bstract—Although most anti-epileptic drugs are considered
o have a primary molecular target, it is clear that their ac-
ions are unlikely to be limited to effects on a single aspect of
nhibitory synaptic transmission, excitatory transmission or
oltage-gated ion channels. Systemically administered drugs
an obviously simultaneously access all possible targets, so
e have attempted to determine the overall effect of diverse
gents on the balance between GABAergic inhibition, gluta-
atergic excitation and cellular excitability in neurones of the
at entorhinal cortex in vitro. We used an approach developed
or estimating global background synaptic excitation and
nhibition from fluctuations in membrane potential obtained
y intracellular recordings. We have previously validated this
pproach in entorhinal cortical neurones [Greenhill and
ones (2007a) Neuroscience 147:884–892]. Using this ap-
roach, we found that, despite their differing pharmacology,
he drugs tested (phenytoin, lamotrigine, valproate, gabapen-
in, felbamate, tiagabine) were unified in their ability to in-
rease the ratio of background GABAergic inhibition to glu-
amatergic excitation. This could occur as a result of de-
reased excitation concurrent with increased inhibition
phenytoin, lamotrigine, valproate), a decrease in excitation
lone (gabapentin, felbamate), or even with a differential in-
rease in both (tiagabine). Additionally, we found that the
ffects on global synaptic conductances agreed well with
hole cell patch recordings of spontaneous glutamate and
ABA release (our previous studies and further data pre-
ented here). The consistency with which the synaptic inhi-
ition:excitation ratio was increased by the antiepileptic
rugs tested was matched by an ability of all drugs to con-
urrently reduce intrinsic neuronal excitability. Thus, it
eems possible that specific molecular targets among anti-
pileptic drugs are less important than the ability to increase
he inhibition:excitation ratio and reduce overall neuronal
nd network excitability. © 2010 IBRO. Published by Elsevier
td.
Corresponding author. Tel: 44-1225-383935; fax: 44-1225-386114.
-mail address: r.s.g.jones@bath.ac.uk (R. S. G. Jones).
bbreviations: aCSF, artificial cerebro-spinal fluid; AED, antiepileptic
rugs; AMPAr, AMPA-receptors; AP, action potential; Ebg, background
xcitation; EC, entorhinal cortex; GABAAr, GABAA-receptors; GABABr,
ABAB-receptors; Ibg, background inhibition; IEI, interevent interval;
S, Kolmogorov–Smirnov; NBQX, 6-nitro-7-sulphamoylbenzo[f]qui-
oxalone-2,3-dione disodium; NMDA, N-methyl-D-aspartate; NMDAr,
MDA-receptors; PDC, L-trans-pyrrolidine,2–4,dicarboxylate; sEPSC,
pontaneous excitatory postsynaptic current; sIPSC, spontaneous in-
ibitory postsynaptic current; TTX, tetrodotoxin; VGCC, voltage gated
alcium channels; VGNC, voltage-gated Na-channels; VmD, mem-
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rane potential distribution; 2-AP5, 2-amino-5-phosphonopentanoic
cid; 4-AP, 4-aminopyridine.
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ntiepileptics.
ntiepileptic drugs (AED) comprise a heterogeneous group
f agents with diverse mechanisms of action. Many have
ultiple effects on neuronal activities and overall mecha-
isms of action are a source of debate. As a generaliza-
ion, antiepileptic drugs aim to modify the dynamic balance
etween inhibition and excitation in neuronal circuits by
argeting membrane ion channels, transmitter receptors
nd metabolic pathways. Attempts to categorize AED ac-
ording to their molecular targets have generally assigned
hem to three main groups; those that block voltage gated
on channels (Na and Ca), and those that either enhance
ABAergic inhibition (by altering GABA synthesis/break-
own or potentiating GABAA-receptor (GABAAr) activity) or
educe glutamatergic excitation (blocking glutamate recep-
ors, reducing glutamate release) (e.g. Rogawski and Los-
her, 2004; Landmark, 2007; White et al., 2007). However,
ED are administered systemically and access all ele-
ents of the neuronal networks. Thus, the specific molec-
lar targets of the drugs may be less important in control-
ing epilepsy than the overall global effects on network
xcitability.
Recently, using whole-cell patch clamp recordings of
pontaneous excitatory postsynaptic currents (sEPSCs)
nd spontaneous inhibitory postsynaptic currents (sIPSCs),
e have shown that a number of clinically effective drugs
an modify the spontaneous release of glutamate and
ABA in the rat entorhinal cortex (EC). Phenytoin and
amotrigine both elicited a presynaptic modulation of glu-
amate and GABA release, decreasing the former, but
oncurrently increasing the latter (Cunningham et al.,
000; Cunningham and Jones, 2000). Neither effect was
elated to drug action at voltage-gated Na-channels
VGNC). Valproate also decreased spontaneous gluta-
ate release, but this effect was likely to be due to block-
de of VGNC in presynaptic axons (Cunningham et al.,
003). Unlike phenytoin and lamotrigine, valproate also
eakly decreased GABA release (again by blocking
GNC), but at the same time prolonged the decay time of
IPSCs, probably by a postsynaptic effect. In other studies
e have shown that gabapentin, pregabalin (Cunningham
t al., 2004) and felbamate (Yang et al., 2007) also de-
rease glutamate release, albeit by different mechanisms,
nse. 
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S. D. Greenhill and R. S. G. Jones / Neuroscience 167 (2010) 456–474 457ut have little effect on GABA release (Jones, unpublished
bservations; current paper).
The overall significance of the effects on spontaneous
lutamate and GABA release in the mechanism of action
f AED is unclear as yet. However, continuous spontane-
us release of both glutamate and GABA resulting from
ction potentials within network interconnections, and also
n the form of mono-quantal, activity-independent release
miniature events), is a characteristic of cortical neurones.
n increasing school of thought suggests that such back-
round activity strongly modifies signal detection. Thus,
he relative level of inhibitory and excitatory background
ctivity is a reflection of ongoing network activity and is
nstrumental in determining the excitability of any given
eurone (Pare et al., 1998; Stevens and Zador, 1998;
estexhe and Pare, 1999; Ho and Destexhe, 2000; Ru-
olph and Destexhe, 2001; Stacey and Durand, 2000;
ellous et al., 2003; Shu et al., 2003a,b). We have previ-
usly speculated that the balance of spontaneous inhibi-
ion and excitation is a determinant of excitability in EC
eurones (Jones and Woodhall, 2005).
Our patch clamp studies clearly show that there is a
iversity of effects of AED on background transmitter re-
ease, but again we are looking at target specific effects.
e believe that is essential to determine the relative
hange in global background synaptic activities and how
his relates to neuronal excitability. Whole cell patch clamp
tudies are limited in several respects. Experimental con-
itions are tailored towards recording of either excitatory or
nhibitory events in isolation. Recording both inhibitory and
xcitatory activity simultaneously is possible, but this
laces significant limits on recording quality. Soma record-
ngs may not adequately detect distal dendritic events that
ontribute to overall cellular activity. Manipulations aimed
t improving space-clamp and, thus, recording resolution
blockade of VGNC and some K-channels) mean that re-
listic estimation of postsynaptic cellular excitability is im-
ossible. To overcome these problems and obtain esti-
ates of background synaptic activity we have begun to
se an approach described by Rudolph et al. (2004),
hereby estimates of global background synaptic excita-
ion (Ebg) and inhibition (Ibg) are derived simultaneously
rom fluctuations in membrane voltage obtained from
harp electrode intracellular recordings. This has been
ermed the membrane voltage distribution (VmD) ap-
roach. Intracellular recordings preserve the intracellular
ilieu and thus also allow for estimates of cellular excit-
bility. We have validated this approach in a previous
aper and shown that it can usefully be applied to intra-
ellular recordings taken from EC neurones in slices
Greenhill and Jones, 2007a). Using the VmD approach,
e have now determined the ratio of background inhibition
o excitation in layer III neurones in the EC. We find that
his global ratio is consistently altered in favour of in-
reased inhibition by all AED tested, regardless of their
pecific molecular targets. At the same time the drugs elicit
consistent decline in neuronal excitability. Some of these
esults have been reported in abstracts (Greenhill and
ones, 2007b; Greenhill et al., 2008, 2009). aEXPERIMENTAL PROCEDURES
lice preparation
ll experiments were performed in accordance with the U.K. An-
mals (Scientific Procedures) Act 1986, European Communities
ouncil Directive 1986 (86/609/EEC) and the University of Bath
thical review document. The number of animals used was kept to
minimum and every precaution was taken to minimize any
uffering and stress inflicted. EC slices were prepared from male
istar rats (60–70 g, bred in-house) as described previously
Jones and Heinemann, 1988). They were anaesthetized with
etamine (120 mg/kg; Fort Dodge Animal Health Ltd., Southamp-
on, UK) and xylazine (8 mg/kg; Bayer plc, Bury St Edmunds, UK)
dministered by intra-muscular injection. After decapitation the
hole brain was quickly removed and immersed in chilled (4 °C)
xygenated (95% O2/5% CO2) artificial cerebrospinal fluid (aCSF)
ontaining ketamine (10 M). The use of ketamine as an anaes-
hetic, and in the cutting solution greatly improves the viability and
urability of the slices, presumably by blocking excitotoxic effects
f NMDAr activation during preparation. Residual blockade of the
MDAr rapidly disappears during storage and recovery evidenced
y the ability to record pronounced NMDAr mediated effects dur-
ng subsequent recordings (e.g. Cunningham et al., 2000; Dhillon
nd Jones, 2000; Woodhall et al., 2001) Slices (400 m) were cut
ith a Vibroslice (Campden Instruments, Loughborough, UK) and
ransferred to a holding chamber containing aCSF (without ket-
mine) at room temperature. After a recovery period of at least
h, individual slices were transferred to an interface chamber
erfused with oxygenated aCSF (1.5 ml/min) maintained at 32
.5 °C for recording. ACSF consisted of (in mM): NaCl (126), KCl
3.75), MgSO4 (1.5), NaHCO3 (23), NaH2PO4 (1.4), CaCl2, (2) and
-glucose (10), pH 7.4 at recording temperature.
mD experiments
ntracellular voltage recordings were made with sharp electrodes
lled with potassium acetate (3 M) from pyramidal neurones in
ayer III of the medial EC using an Axoprobe 1A amplifier (Molec-
lar Devices, Sunnyvale, CA, USA) in bridge mode. Data were
cquired using a Digidata 1200 and Axoscope software. Typically
n6), these neurones had a resting potential of 72.20.5 mV,
nput resistance of 796 m and action potential amplitude (from
hreshold) and half-widths of 72.11.6 mV and 0.320.01 ms,
espectively. In an initial series of experiments synaptic responses
ere evoked via a bipolar stimulating electrode placed in the
ateral EC. In six neurones excitatory postsynaptic potentials
ediated by AMPA receptors (AMPAr) were isolated by blockade
f NMDA-receptors (NMDAr, 2-AP5), GABAAr (bicuculline) and
ABAB-receptors (GABABr, CGP 55845A). The mean reversal
otential of AMPAr-mediated responses (6.62.0 mV) was de-
ermined by recording excitatory postsynaptic potentials at differ-
nt membrane potentials. Similar experiments (n6) were per-
ormed, substituting an AMPAr antagonist (NBQX) for the
ABAAr-antagonist, in the blocking cocktail, to determine the
eversal potential (66.71.0 mV) of GABAAr-mediated inhibitory
ostsynaptic potentials.
At regular intervals throughout the recordings, following an
quilibration time of 5–10 min after stabilization of resting poten-
ial, estimates of Ebg and Ibg were made using the VmD method
erived by Rudolph et al. (2004), and as previously described
Greenhill and Jones, 2007a). Briefly, neurones were depolarised
for 15–20 s) by injection of two levels of known positive current
Iext1 and Iext2) via the recording electrode. The values of the
urrents differed from neurone to neurone, but were maintained
he same throughout any individual experiment. Iext2 was chosen
o elicit a depolarization to within 1–2 mV of action potential
hreshold and I was adjusted to depolarize the neurone toext1
bout half way between Iext2 and resting membrane potential.
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S. D. Greenhill and R. S. G. Jones / Neuroscience 167 (2010) 456–474458embrane potential fluctuations at these two levels were fitted to
aussian distributions (using Prism 4 software, GraphPad, San
iego, CA, USA) and the mean and variance of the membrane
otential determined. Leak conductance in each neurone was
alculated from the ohmic response produced by a small (0.1 nA,
00 ms) hyperpolarizing current, injected at resting membrane
otential. These parameters, together with the mean reversal
otentials derived from the preliminary experiments, allowed us to
se the VmD relationship (equation 11 in Rudolph et al., 2004) to
uantify background inhibitory and excitatory conductances re-
ulting from global network input to individual neurones.
Cellular excitability was determined by injecting depolarizing
urrent pulses at resting potential during intervals between Ebg
nd Ibg estimates. Firstly, action potential (AP) thresholds were
etermined using brief incremental peri-threshold injections of
epolarizing current (0.1–1.0 nA, 50 ms) via the recording elec-
rode, with firing threshold measured with respect to resting mem-
rane potential. Secondly, trains of action potentials were elicited
y longer, supra-threshold current steps (0.4–1.5 nA, 250 ms),
nd the number of spikes per step depolarization determined.
ction potential amplitudes (from rest) and half-widths were also
nalyzed.
Statistical analysis (paired t-test or one-way ANOVA) was
erformed with Prism 4 software. All values are expressed as
eanSEM.
hole-cell patch clamp recordings
e had not previously reported the effects of some of AED tested
n sEPSCs and sIPSCs. To provide a more complete correlation
etween these effects and the corresponding VmD estimations of
bg and Ibg, we tested the effects of felbamate and gabapentin on
IPSCs, and tiagabine on both sIPSCs and sEPSCs.
Slices were prepared as described above. For recording
EPSCs, patch pipettes were filled with a Cs-gluconate based
olution containing (in mM) D-Gluconate (100), HEPES (40), QX-
14 (1), EGTA (0.6), MgCl2 (5), TEA-Cl (10), phosphocreatinine
5); ATP-Na (4) and GTP-Na (0.3). To record sIPSCs the patch
olution contained CsCl (100), HEPES (40), QX-314 (1), EGTA
0.6), TEA-Cl (10), MgCl2 (5), ATP-Na (4) and GTP-Na (0.3).
olutions were adjusted to 275 mOsmol, and to pH 7.3 with
sOH. Whole-cell voltage clamp recordings (holding potential
60 mV unless otherwise stated) were made from neurones in
ayer III of the medial division of the EC, using an Axopatch 200B
mplifier. Signals were filtered at 2 kHz and digitized at 20 kHz.
eries resistance compensation was not employed, but access
esistance (10–30 M) was monitored at regular intervals
hroughout each recording and cells were discarded from analysis
f it changed by more than 10%.
To compare sPSCs we measured amplitudes, inter-event
ntervals (IEI), 10–90% rise times, and total decay times. In some
ases, we found complex effects on sPSCs (e.g. decrease in
requency, increase in decay time) so to gain an overall picture of
he effects of drugs on the level of spontaneous inhibition or
xcitation we estimated total charge transfer associated with
IPSCs and sEPSCs. This is calculated by measuring the area of
IPSCs or sEPSCs, and is directly proportional to the amplitude
ultiplied by the decay time (Hollrigel and Soltesz, 1997). We
etermined charge transfer associated with sPSCs in a set time
eriod of 2 min in control and in the presence of the drug. Mean
alues for all parameters of sPSCs were compared using a paired
-test, with significance set at P0.05. For additional comparison
f IEI we used the non-parametric Kolmogorov–Smirnov test (KS)
pplied to cumulative probability distributions. When pooling data
or this comparison we included a minimum of 200 events from
ach neurone in the control situation and an equal number of
vents in the presence of the drug. Significance was set at
0.01. naterials
he following drugs were used: felbamate (2-phenyl-1,3-pro-
anediol dicarbamate, Sigma-Aldrich, UK), gabapentin (1-(amin-
methyl)cyclohexaneacetic acid, a gift from Pfizer Global R and D,
nn Arbor, MI, USA), lamotrigine (6-(2,3-dichlorophenyl)-1,2,4-
riazin-3,5-diamine, Tocris, UK), phenytoin (5,5-diphenylhydan-
oin, Sigma-Aldrich, UK), sodium valproate (Sigma-Aldrich, UK),
iagabine (Tocris, UK), NBQX (6-nitro-7-sulphamoylbenzo[f]qui-
oxalone-2,3-dione disodium, Tocris, UK), 2-AP5 (2-amino-5-
hosphonopentanoic acid, Tocris, UK), bicuculline methochloride
Tocris, UK), PDC (L-trans-pyrrolidine,2–4,dicarboxylate, Tocris, UK),
GP 55845A ((2S)-3-[[(1S)-1-(3,4-dichlorophenyl)ethyl]amino-2-
ydroxypropyl](phenylmethyl)phosphinic acid, a gift from Novartis
nternational AG, Basel, Switzerland), fluoxetine (Ascent Scien-
ific, UK), clozapine (Ascent Scientific, UK), 4-AP (4-aminopyri-
ine, Sigma-Aldrich, UK), TTX (Alamone Labs, Israel). All drugs
ere applied by bath perfusion. QX-314 (Tocris, UK) was included
n patch pipette solutions. We based the concentrations of AED
nd other drugs on those that have been employed in a large
ariety of other pharmacological experiments in the literature in-
luding our own (e.g. Cunningham et al., 2000, 2003, 2004; Cun-
ingham and Jones, 2000; Yang et al., 2007). These have been
ased as far as possible on the therapeutic range of brain con-
entrations described in the literature (e.g. see Rogawski and
orter, 1990). In the main, we kept our test concentrations at the
ower end of the range at which significant pharmacological ac-
ions might be expected without direct effects on excitability, as we
ished to correlate changes in synaptic activity with excitability
hanges. We accept that higher or lower concentrations may have
ifferent effects on background excitation and inhibition to those
eported here.
RESULTS
he experiments described below involved recordings (in-
racellular and patch clamp) obtained from a total of 96
eurones of the medial EC. In sharp electrode recordings
e selected neurones in layer III as pyramidal, based on
ring characteristics, using criteria established from a pre-
ious study using sharp electrode recording and biocytin
lls (Dhillon and Jones, 2000). In whole-cell patch record-
ngs, neurones were visually identified in slices using IR-
IC, and those with clear pyramidal morphology selected
or recording. We cannot guarantee that every neurone
ecorded from was a pyramid but it is likely that the vast
ajority is.
In VmD experiments (n48) the mean control values
f Ibg in layer III neurones was 6.30.9 nS. Ebg was
onsiderably lower at 1.70.3 nS and the mean I:E ratio
as 4.00.3. This predominance of background inhibition
ver excitation is similar to that reported previously in vitro
Rudolph et al., 2004; Greenhill and Jones, 2007a) and
lso in similar estimates in vivo (Rudolph et al., 2007).
here was a marked variation in control values from neu-
one to neurone, but Ibg was always higher than Ebg.
ffects of AED
Phenytoin. The effects of phenytoin (20 M) were
ested on six neurones and the results are summarized in
ig. 1. In control recordings the mean value of Ibg was
.10.7 nS, and E was almost fivefold lower at 1.10.2bg
S, resulting in a mean I:E ratio of 5.10.7 (Fig. 1A). In the
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S. D. Greenhill and R. S. G. Jones / Neuroscience 167 (2010) 456–474 459resence of phenytoin, Ibg increased to 9.31.6 nS
P0.05, paired t-test). Concurrently, Ebg decreased by
09% to 0.60.2 nS, although this just failed to reach
ignificance. However, the I:E ratio showed a pronounced
ncrease in favour of inhibition, to 24.67.3 (548212%;
0.05; Fig. 1A). These effects are in good agreement
ith our previous patch clamp experiments in EC neu-
ig. 1. Effect of phenytoin on background synaptic conductances and
ecreased background excitation (Ebg). The net result of this was a fiv
he increase in I:E ratio was accompanied by reduced excitability. Th
ulses was reduced. Spike amplitude was unchanged. (C) Intracellula
hows typical responses evoked by depolarizing current in layer III pyr
he bottom line shows that the current required to elicit a spike at th
uration pulse was used to elicit repetitive firing, the number of spi
ignificant difference compared to control values (P0.05, paired t-teones. In these we showed that phenytoin, at the same ioncentration employed here, acted presynaptically to in-
rease the spontaneous release of GABA, but to decrease
he release of glutamate (Cunningham et al., 2000; Yang
t al., 2007).
Concurrent with the increase in I:E ratio induced by
henytoin, the drug also significantly altered neuronal ex-
itability. Thus, in the six neurones tested, AP threshold
y. (A) Phenytoin concurrently increased background inhibition (Ibg) but
ease in the I:E ratio. (B) Measures of cellular excitability indicate that
threshold was elevated and repetitive firing during long depolarizing
gs from one neurone illustrating the excitability change. The top line
urones (shown by the reconstructed neurone following a biocytin fill).
as larger in the presence of the drug. When a supra-threshold, long
ed was reduced in the presence of phenytoin. Asterisks indicate aexcitabilit
efold incr
us, spike
r recordin
amidal ne
reshold w
kes evokncreased from 17.11.0 mV positive to EM to 24.31.0
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S. D. Greenhill and R. S. G. Jones / Neuroscience 167 (2010) 456–474460V (P0.05, t-test). The number of APs generated during
long depolarizing current step fell from 5.30.5 to
.50.3 (P0.001, t-test). However, there was no change
n action potential amplitude (96.52.1 versus 98.21.9
V) or half width (0.410.03 versus 0.390.01 ms). Ad-
itionally, during evoked spike trains, phenytoin did not
ignificantly change the amplitude of the final action po-
ential in each train, or the relative amplitudes of the first
nd last spikes (not shown). The results in the six neu-
ones tested are summarized in Fig. 1B. Fig. 1C shows
esponses of one neurone to depolarizing current pulses
nd illustrates the increased amplitude of a short current
ulse to elicit a spike at threshold, and the decreased
umber of spikes in the train evoked by the long, supra-
hreshold step. Thus, in summary, phenytoin induced an
ncrease in I:E ratio, which was concurrent with a de-
reased neuronal excitability, but without directly affecting
P generation.
Lamotrigine. Results with lamotrigine (20 M) were
ery similar to those noted with phenytoin. During applica-
ion of the drug, Ibg increased progressively from a control
alue of 5.32.0 to 13.22.6 nS after 15 min (P0.05).
oncurrently, Ebg decreased from 1.50.4 to 1.10.4 nS.
he large variation in Ebg in this sample of neurones meant
hat the difference just failed to reach significance. Notice-
ble, however, was the marked change in I:E ratio. From a
ontrol value of 4.00.7, this increased to 17.55.0 nS
P0.05) a mean increase of 434112% in favour of
nhibition in the six neurones tested. Again, the results
btained with lamotrigine in the VmD estimates agree with
hose obtained in whole cell patch clamp recordings,
here we showed a decrease in frequency of sponta-
eous AMPAr mediated sEPSCs concurrent with an
ncrease in GABAAr-mediated sIPSCs (Cunningham and
ones, 2000).
The pronounced increase in I:E ratio was paralleled by
decline in neuronal excitability. Spike threshold in-
reased from 25.33.3 mV in control to 29.13.8 mV after
5 min (P0.05). The number of spikes generated by a
50 ms depolarizing step decreased from 5.30.8 to
.30.6 (P0.05). Spike amplitude (94.20.7 versus
5.50.9 mV) and half width (0.370.01 versus 0.40.02
s) were unaltered.
Thus, as with phenytoin, an overall increase in global
nhibition by lamotrigine was accompanied by a decrease
n neuronal excitability, with no apparent deleterious ef-
ects on spike generation. We tested a higher concentra-
ion (200 M) of lamotrigine in two neurones. This re-
ulted an increase in mean Ibg from 5.5 to 27.7 nS and
decrease in Ebg from 1.6 to 0.8 nS, with a huge
oncomitant increase in I:E from 3.6 to 29.5. However,
lthough spike threshold (27.2 versus 31 mV) and spike
requency (3.7 versus 1.0) were both clearly reduced,
here was also a substantial decrease in spike amplitude
94.7 versus 77.7 mV) and increase in half-width (0.31
ersus 0.52 ms) as well in these two neurones. Thus,
lthough the higher concentration of the drug had qual- ntatively similar effects in VmD studies, it was clearly
lso affecting spike generation.
Carbamazepine. Carbamazepine is generally cate-
orized alongside phenytoin and lamotrigine as a front-line
reatment for partial and generalised tonic-clonic seizures,
ith VGNC as a primary molecular target (Rogawski and
oscher, 2004; White et al., 2007). In VmD studies it had a
ery similar effect to the other two drugs. Thus, it elevated
bg from 4.71.8 to 11.22.6 nS after 15 min of perfusion
P0.05, n4), while Ebg was decreased from 2.10.4 to
.30.8 nS, although the latter was not significant. Overall,
he I:E ratio rose from 3.81.1 to 11.91.9 (P0.05).
easures of cellular excitability also showed the same
hanges seen with phenytoin and lamotrigine with an in-
rease in spike threshold and a decrease in the number of
pikes evoked during prolonged depolarization, but no
lteration in spike parameters (not shown).
Valproate. Valproate is generally considered to be a
road spectrum AED, used to treat generalized (tonic-
lonic and absence) and partial seizures. During perfusion
ith valproate (500 M, n6) we recorded an elevation in
ackground inhibition, with Ibg increasing from 10.22.0 to
3.14.4 nS after 15 min (P0.05). Conversely, there was
significant decline in Ebg from 2.80.4 to 1.70.3 nS
P0.05). These concurrent changes again resulted in
substantial change in the I:E ratio, from 3.60.4 to
4.13.0 (P0.05). In these experiments we monitored
he time course of the changes in background conduc-
ances, and this is illustrated in Fig. 2A. Interestingly, after
min, there was a slight decline in Ibg. However, this was
ot significant and thereafter a progressive rise was re-
orded. In contrast, Ebg declined steadily throughout the
5-min recording period.
In previous whole cell patch clamp experiments (Cun-
ingham et al., 2003) we found that valproate decreased
he frequency of sEPSCs and also that of sIPSCs, albeit
ore weakly, contrasting with lamotrigine and phenytoin,
hich decreased the former but increased the latter. We
howed that both effects were probably due to blockade of
GNC in presynaptic axons/terminals. At first sight this is
t odds with the observation in the current experiments
hat the drug increased Ibg. However, although valproate
ecreased the frequency of sIPSCs it prolonged their de-
ay time without effect on amplitude (Cunningham et al.,
003). To look at this in more detail we have reanalysed
he data from these experiments to calculate the inhibitory
harge transfer in the presence and absence of valproate.
his analysis gave a mean inhibitory charge transfer of
352.8331 pC in control conditions but, despite the re-
uction in frequency, 1727391 pC in the presence of
alproate. Thus, the increased duration of sIPSCs induced
y the drug appears to compensate for the reduced num-
er of events and would be in line with the increase in
lobal background inhibition over excitation recorded in
ur VmD analysis.
Valproate, like phenytoin and lamotrigine, also de-
ressed neuronal excitability Pooled data from the six
eurones tested are shown in Fig. 2B and responses from
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reased from 17.83.6 to 24.23.2 mV after 15 min
P0.05), while the number of spikes generated by the
ong depolarizing pulse fell from 5.71.1 to 0.60.5
P0.05). Interestingly, spike amplitude was not affected,
nd actually increased slightly (though not significantly)
ig. 2. Valproate also increases I:E ratio. (A) Summary of the time
all in Ibg, with a subsequent elevation. Ebg was progressively reduc
nd (C) show that this change was accompanied by similar chang
ndicate a significant difference compared to control values (P0.0rom 94.23.3 to 97.32 mV. Spike half-width was unal- sered (0.360.01 versus 0.380.02 ms). In whole cell
atch clamp experiments the decrease in sIPSC and
EPSC frequency were obviated by prior application of
TX suggesting that valproate was blocking VGNC and
pike generation in presynaptic axons. Thus, it may be that
resynaptic action potential generation may be more sen-
f changes in six neurones over 15 min. There was an initial slight
hout, and overall there was a progressive increase in I:E ratio. (B)
citability to those seen with phenytoin and lamotrigine. Asterisks
t-test).course o
ed throug
es in exitive to valproate than postsynaptic.
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S. D. Greenhill and R. S. G. Jones / Neuroscience 167 (2010) 456–474462Gabapentin. Gabapentin is one of the newer gener-
tion of AEDs, and is licensed for use in partial epilepsies
ith or without secondary generalization. It is a GABA
nalogue originally designed to act as a brain-penetrant
ABAr-agonist but the consensus of opinion is that it
enerally has little effect at GABA receptors or other ele-
ents of GABAergic systems (Taylor et al., 1998). It has
een shown to a interact with the 2-auxiliary subunit of
oltage gated calcium channels (VGCC), and in whole cell
atch clamp studies we found that gabapentin reduced
oth evoked and spontaneous release of glutamate at EC
ynapses (Cunningham et al., 2004; Yang et al., 2007).
his appeared to be due partly to blockade of P/Q-type
GCC, and partly due to an effect on glutamate release
ownstream of Ca-entry.
We have now tested the effect of gabapentin on
ABAAr-mediated sIPSCs in 6 EC neurones using whole
ell patch clamp. In these neurones sIPSCs had a mean
EI of 15531 ms (corresponding to a frequency of
.12.1 Hz) in control conditions. Gabapentin (25 M)
lightly (but not significantly) reduced sIPSC frequency to
.12.3 Hz (IEI 17138 ms). Likewise, the drug had little
ffect on peak amplitude of sIPSCs (27.61.7 versus
8.82.1 pA), 10–90% rise time (2.20.5 versus 2.40.3
s) or total decay time (17.11.9 versus 18.62.2 ms).
verall, inhibitory charge transfer was very similar
hether the drug was present (779.4224 pC) or absent
687271 pC).
So in whole cell clamp studies gabapentin decreased
pontaneous glutamate release but had no effect on
ABA. In agreement with these data, and in contrast to the
ther AED described above, gabapentin (25 M) had little
ffect on Ibg in six neurones where we conducted VmD
nalysis. In control recordings Ibg was 4.51.3 nS and this
as unaltered after 15 min perfusion with gabapentin
4.91.3 nS). However, Ebg was more than halved
1.20.3 to 0.50.1 nS, P0.05, t-test), again in good
greement with our patch clamp studies (Cunningham et
l., 2004). Thus, although background inhibition per se
as largely unaltered by gabapentin, the slight increase,
ogether with the decline in background excitation meant
hat I:E ratio was again significantly increased from
.10.7 to 8.61.9 in favour of inhibition (Fig. 3A; P0.05,
-test).
The shift in I:E ratio by gabapentin was accompanied
y changes in excitability, as with the other AEDs (Fig. 3A).
ction potential threshold increased from 19.30.8 to
3.00.3 mV after 15 min (P0.05, t-test). The decrease
n number of spikes evoked by a depolarizing pulse was
ot quite as marked as with other drugs tested (5.20.3 to
.30.2), but was, nevertheless, still significant (P0.05,
-test). Spike amplitude was unaltered (Fig. 3A).
Felbamate. Felbamate was the first of the new gen-
ration of AED and was first introduced in 1993 for the
reatment of a wide spectrum of seizures including partial,
rimary and secondarily generalized seizures, and Len-
ox–Gastaut syndrome. However, hepatic and haemato- sogical toxicity mean its use is now limited to treatment of
he latter and other refractory epilepsies.
We have previously reported that low concentrations of
elbamate reduce the frequency of sEPSCs in whole cell
atch clamp recordings by around 50% (Yang et al., 2007).
he drug has repeatedly been shown to be an antagonist
t NMDAr, and our data suggested that its effects on
pontaneous glutamate release were likely to be due to
lockade of presynaptic facilitatory NMDA autoreceptors
see Berretta and Jones, 1996; Woodhall et al., 2001). We
ave tested the effect of felbamate (100 M) in VmD
tudies (n6). In line with the whole cell patch studies Ebg
as substantially reduced from 2.31.3 to 0.40.1 nS
Fig. 3B).
Previous reports have suggested felbamate can en-
ance GABAAr mediated currents in cortical neurones
Kume et al., 1996; Rho et al., 1997), although studies in
enopus oocytes indicated a positive or negative modula-
ion, depending on receptor subunit composition (Simeone
t al., 2006). However, in our VmD experiments, Ibg was
lightly, but not significantly reduced in the presence of
elbamate (6.72.2 versus 5.41.4 nS; Fig. 3B). To clarify
nd complement this observation we conducted whole cell
atch clamp studies on sIPSCs in six EC neurones. Appli-
ation of felbamate (100 M) caused a small, but non-
ignificant decrease in frequency of sIPSCs (IEI 16936
ersus 20154 ms). In addition, the mean amplitude
31.22.1 versus 28.92.6 pA), rise (1.90.5 versus
.80.3 ms) and decay time (15.41.8 versus 16.82.0
s) of these events were also unaltered.
Thus, the patch clamp studies are in agreement with
he lack of change in Ibg. However, the concurrent decline
n Ebg resulted in a cumulative change in I:E ratio from
.61.0 to 15.63.5; P0.05, t-test, favouring back-
round inhibition (Fig. 3B). Again, this relative change in
bg and Ebg proved to be a good predictor of changes in
euronal excitability (Fig. 3B). Thus, spike firing threshold
as raised from 20.31.7 to 24.41.0 mV (P0.05) by
he addition of felbamate and the number of spikes gener-
ted by the 250 ms depolarizing pulse fell by about 50%
5.20.4 to 2.50.2; P0.05). Although, very high con-
entrations of felbamate have also been reported to inhibit
GNC (Taglialatela et al., 1996) it had no effect on either
pike amplitude (97.92.6 versus 96.73.0 mV) or half-
idth (0.420.02 versus 0.400.03 ms) in our studies.
Tiagabine. Tiagabine is a selective GABA-reuptake
nhibitor structurally related to nipecotic acid. It has been
uccessfully used as add-on therapy in the treatment of
artial epilepsies (Bauer and Cooper-Mahkorn, 2008).
mD estimates were obtained from a total of six neurones.
erhaps unsurprisingly, tiagabine (4 M) caused a sixfold
ise in Ibg from a control level of 8.12.1 to 48.816.8 nS
P0.05). Interestingly, however, Ebg was also increased
ut to a much lesser extent, from 1.80.4 to 3.91.0 nS
P0.05). Nevertheless, although Ebg was more than dou-
led, the overall change in both conductances again
hifted the I:E ratio heavily in favour of inhibition, from
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S. D. Greenhill and R. S. G. Jones / Neuroscience 167 (2010) 456–474 463.50.2 to 12.54.4 (P0.05). The data are summarized
n Fig. 4A.
We have also conducted parallel studies of tiagabine
n sIPSCs and sEPSCs to determine if the global changes
etermined from VmD estimates was paralleled by
hanges in spontaneous glutamate and GABA release.
iagabine (4 M, n6) had complex and quite variable
ffects on sIPSCs. Overall IEI increased from 18052 to
5645 ms reflecting a fall in mean frequency from
ig. 3. Summary data for gabapentin and felbamate. (A) Gabapentin d
:E ratio. Concurrently excitability of neurones was reduced. (B) Felba
ecreasing Ebg. It also significantly reduced excitability. The asterisks
significant difference compared to control values (P0.05, paired t-.42.2 to 5.82.3 Hz. KS analysis showed the change in 1EI to be significant (P0.01), although the change in
requency (paired t-test) was not. Recordings from one
eurone are shown in Fig. 4C, together with the cumulative
robability analysis of pooled data from the six neurones
ested. It should be noted that, in the population of neu-
ones tested, four showed a clear decrease in frequency
hereas there was no change in one and a slight increase
n another. In addition to the overall frequency change,
ean sIPSC amplitude increased significantly (from 16.7
Ebg. Despite a lack of effect on Ibg, the drug, nevertheless, increased
mbled gabapentin in that it increased I:E ratio primarily as a result of
significant differences compared to control values. Asterisks indicateecreased
mate rese
indicate.7 to 23.82.7 pA) and this was consistent in all six
n
t
m
i
m
F
o
(
p
(
t
t
s
( s, asses
S. D. Greenhill and R. S. G. Jones / Neuroscience 167 (2010) 456–474464eurones. Concurrently, the drug consistently increased
he total decay time of sIPSCs from 28.60.7 to 37.32.4
ig. 4. Summary of VmD and whole cell patch experiments with tiaga
n the latter resulted in an overall increase in I:E ratio. (B) This was a
C) Recordings of sIPSCs in one neurone show a decrease in freq
robability curves (pooled data from six neurones) show the distribution
t, grey line). Averaged sIPSCs (60 each in control and drug) in one ne
hat the decay is prolonged by tiagabine (grey line). (D) sEPSCs rec
iagabine. The cumulative probability curve of interevent intervals is s
EPSCs in one neurone (90 each in control and drug) overlap almos
A) and (B) indicate significance at P0.05 compared to control values (P0.05). Averaged sIPSCs from one neurone are sllustrated in Fig. 4C to show the prolonged decay time. To
ake an estimate of the overall effect of tiagabine on
) The drug increased both Ebg and Ibg, but a more pronounced effect
ied by a similar decrease in excitability to that seen with other AED.
companied by an increase in amplitude of events. The cumulative
vent intervals shifted to right of control (c) in the presence on tiagabine
also shown. These are scaled to the same peak amplitude and show
one neurone show a clear increase in frequency in the presence of
the left of control (c) in the presence of tiagabine (t). The averaged
showing that the primary effect was on frequency. The asterisks in
sed by paired t-tests, and in (C) and (D) at P0.01 assessed by KS.bine. (A
ccompan
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S. D. Greenhill and R. S. G. Jones / Neuroscience 167 (2010) 456–474 465harge transfer associated with sIPSCs. The mean inhib-
tory charge transfer in control was 548.3161.7 pC, and
his increased to 767.8247.5 pC in the presence of the
rug, a mean increase of 14836%. However, the vari-
bility between cells meant that this did not reach
ignificance.
Tiagabine also had noticeable effects on sEPSCs, and
he data are summarized in Fig. 4D. The most pronounced
ffect was an increase in frequency. Thus, in five neu-
ones, IEI decreased from 432128 to 20460 ms during
pplication of tiagabine (4 M) reflecting an increase in
requency from 3.40.9 to 6.31.2 Hz (P0.05). In four of
ve neurones mean amplitudes increased slightly although
here was no significant change in mean (11.01.6 versus
1.81.9 pA). The decay time of sEPSCs, unlike that of
IPSCs was also unaltered (6.70.7 versus 6.50.6 ms).
o obtain an overall estimate of the change in excitation
esulting from spontaneous glutamate release we calcu-
ated total excitatory charge transfer. In control conditions
his was 34.17.5 pC and in the presence of tiagabine it
as 68.812.6 pC (P0.05), an increase of 11536%.
Thus, despite the relatively complex effects of tiagab-
ne in patch clamp studies, the overall changes in charge
ransfer paralleled the results with VmD estimates, with
oth excitation and inhibition. The increase in I:E ratio
oted in VmD studies was accompanied by similar
hanges in excitability noted for the other AED tested (Fig.
B). Thus, spike threshold was raised from 18.80.5 to
4.90.5 mV (P0.05), and the number of spikes gener-
ted during depolarization fell substantially from 3.50.4
o 1.30.21 (P0.05). As with the other drugs, action
otential amplitude (97.92.8 versus 99.42.3 mV) and
alf-width (0.330.03 ms versus 0.380.03 mV) were
naffected.
ther drugs
t is clear from the above studies that clinically effective
EDs consistently increase the ratio of global background
ynaptic inhibition to excitation and simultaneously de-
rease neuronal excitability. The consistency of these ef-
ects raises the question as to whether these effects may
imply be artefacts of the novel experimental approach,
nd have no relevance to clinical therapeutic actions. As a
ay of controlling for this we have tested a number of
rugs that do not exhibit clinical AED activity.
PDC. As a like-for-like comparison with tiagabine we
ave examined the effect of a glutamate uptake blocker,
DC (100 M) in both VmD and whole cell patch config-
rations. In six neurones, Ebg was increased by PDC from
.00.2 to 2.00.5 nS (P0.05). Concurrently, Ibg also
ncreased (3.91.0 to 8.53.5 nS). The parallel rise in
oth conductances resulted in little overall change in I:E
atio, which was 4.00.5 in control, and 3.90.9 in the
resence of PDC (9619%). The data are summarized in
ig. 5A.
Whole cell patch clamp recordings revealed a number
f effects of PDC on both sEPSCs and sIPSCs. There was
clear effect on the frequency of sEPSCs (Fig. 5C, n6). tEI decreased from 591243 to 345129 ms (P0.01, KS
ig. 5C) during perfusion with PDC reflecting an increase
n frequency from 3.31 to 4.71.1 Hz (P0.05, paired
-test). Although amplitude was unaltered (19.54.0
ersus 19.83.2 pA), total decay time increased from
.10.6 ms to 8.40.9 ms (P0.05, paired t-test). This is
llustrated by the averaged sEPSCs from one neurone
hown in Fig. 5C. Rise time was unaltered (2.50.5 versus
.30.3 ms), but the change in frequency and decay time
ombined to induce a significant increase in total charge
ransfer from 60.222.4 to 101.530.0 pC (P0.05,
aired t-test), a rise of 9324%.
Blocking glutamate uptake also altered spontaneous
ABA release (n6) and the data are illustrated in Fig. 5D.
significant (P0.01, KS) decrease in IEI (from 11016
o 9011 ms) reflected an average increase in sIPSC
requency to 1229% of control in the presence of PDC
10.11.5 to 12.11.5 Hz, P0.05, paired t-test). Addi-
ionally, mean amplitude increased from 22.31.4 to
7.52.8 pA, although this was not significant. Total decay
ime was slightly, but not significantly, longer (12.91.0
ersus 13.81.5 ms). Overall, the change in sIPSC pa-
ameters resulted in a rise in total charge transfer to
6625% of control levels in PDC (435.5113.6 versus
37.7126.7 pC, P0.05, paired t-test).
Thus, the effects of PDC on sEPSCs and sIPSCs are
n concordance with data from VmD studies, which show a
elatively balanced increase in global background inhibi-
ion and excitation. These changes were not accompanied
y any clear alteration of neuronal excitability (Fig. 5B).
hus, spike thresholds were 25.720.5 and 24.30.6 mV
n the absence and presence of PDC, respectively. Spike
mplitude was unchanged (94.20.7 versus 94.60.7
V) as was the number of spikes elicited by a depolarizing
ulse (3.50.4 versus 4.10.5).
Clozapine. Clozapine is an atypical antipsychotic
rug effective against both negative and positive symp-
oms of schizophrenia. One side effect that has long been
nown is promotion of seizures (see Wong and Delva,
007). We have used the VmD approach to determine if it
an alter I:E ratio perhaps leading to increased neuronal
xcitability and proconvulsant effects. In four neurones,
bg was 2.20.6 nS, and this was essentially unaltered
2.50.7 nS) in the presence of clozapine (1 M). Ibg was
lso unaffected (5.11.1 versus 5.91.4 nS) so that I:E
atio showed little change (3.20.5 versus 3.60.4). Con-
urrently there was little change in spike threshold
18.72.1 versus 18.92.0 mV) or number of spikes
voked by a long depolarizing pulse (3.90.1 versus
.90.2).
Fluoxetine. There has been some controversy over
hether antidepressants, including the selective 5HT up-
ake blocker, fluoxetine, may have pro- or anticonvulsant
ffects (see Jobe and Browning, 2005). We have exam-
ned the acute effects of fluoxetine (10 M) in VmD exper-
ments (n4). As with clozapine, fluoxetine induced no
ignificant change in either E (although slightly increasedbg
o 1156% of control) or Ibg (946%), and consequently,
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S. D. Greenhill and R. S. G. Jones / Neuroscience 167 (2010) 456–474466:E ratio (977%). The lack of change in background
onductances was congruent with an unaltered excit-
bility (spike threshold 21.42.7 versus 19.62.9 mV:
umber of spikes 4.50.6 versus 3.80.7). Similar data
ere obtained with another antidepressant, desipramine
ig. 5. Summary of VmD and whole cell patch experiments with PDC
onductances. However the much lesser effect on Ibg meant that ther
xcitability. (C) Recordings of sEPSCs show that the drug primarily inc
ncreased the frequency of sIPSCs but did not alter decay time. The a
ndicate a significant difference compared to control values (P0.01,not shown). sffects of convulsant treatments
iven the consistent changes in ratio of background inhi-
ition to excitation noted with a range of AED, it was of
nterest to determine what effect treatments that provoke
tiagabine, the glutamate uptake blocker increased both background
overall change in I:E ratio. (B) There was little concurrent change in
he frequency of events and prolonged their decay time. (D) PDC also
indicate significant differences compared to control values. Asterisks. (A) Like
e was no
reased t
sterisksynchronized epileptiform activity would have. To this end
w
c
c
m
e
e
r
g
i
w
f
b
t
s
a
f
w
e
u
T
i
s
g
e
i
i
t
s
1
c
t
n
(
[
F
n
i
d
m
a
S. D. Greenhill and R. S. G. Jones / Neuroscience 167 (2010) 456–474 467e examined the effects of the GABAA-antagonist, bicu-
ulline, reduction of [Mg2]o, and the transient A-type K
-
hannel blocker, 4-aminopyridine (4-AP). All three treat-
ents resulted in the induction of spontaneous, recurrent
pileptiform activity. Once this stage was reached, it was
xtremely difficult to obtain the stable membrane potential
equired for VmD estimates, so the data below were mostly
athered in the period before epileptiform activity was
nitiated. When the initial rate of discharges was low, we
ere able to continue measurements for a short period
ollowing this.
Bicuculline. We previously reported the effects of
icuculline on global inhibition and excitation at a single
ime point (Greenhill and Jones, 2007). In the current
tudies we have followed the time course of changes in Ibg
nd Ebg during perfusion with the blocker. Summary data
or five neurones are shown in Fig. 6A. It is clear that there
as a rapid and progressive decrease in Ibg in the pres-
ig. 6. Background synaptic conductances during blockade of GABAA
5), which reached the recording chamber at time zero. The drug i
ncrease in Ebg. This resulted in a fall in I:E ratio to the point were the c
ischarges became apparent. These usually presented as an initial a pr
uch briefer (B). (C) Shows that cellular excitability was increased at time close
significant difference compared to control values (P0.05, paired t-test).nce of the GABA-antagonist. At the same time, Ebg grad-
ally rose although at no point did this reach significance.
hese combined changes resulted in a precipitous decline
n I:E ratio. After 8 min the ratio was around 1:1 from a
tarting point of over 9:1. Also shown on the time course
raphs in Fig. 6, is the mean point at which spontaneous
pileptiform events became apparent. In most cases the
nitial event was a long-lasting ictal-like discharge and was
mmediately followed by regular, brief (150–450 ms dura-
ion) interictal-like events (Fig. 6B), which have been de-
cribed previously (e.g. Jones, 1988; Jones and Lambert,
990a). At this stage, I:E ratio was approaching unity and
ellular excitability was increased (Fig. 6C), with spike
hreshold lower (20.61.1 versus 18.20.9 mV) and the
umber of spikes evoked by a depolarizing pulse elevated
4.30.3 to 5.51.0 mV).
Low-Mg2. The epileptogenic effects of lowering
Mg2]o in the EC have been described in detail previously
aph in (A) shows the time course of the effects of bicuculline (10 M;
substantial and progressive decrease in Ibg with a concurrent weak
ces were approximately equal. At this stage synchronous epileptiform
event, which was succeeded by regular recurrent discharges that werer. The gr
nduced a
onductan
olongedto when epileptiform discharges became apparent. Asterisks indicate
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S. D. Greenhill and R. S. G. Jones / Neuroscience 167 (2010) 456–474468Walther et al., 1986; Jones and Heinemann, 1988; Jones
nd Lambert, 1990b). We examined the effects of progres-
ively reducing [Mg2]o from 1.5 to 1.0, 0.5 and then
ominally 0 mM in six neurones. The results are summa-
ized in Fig. 7A. In control conditions (1.5 mM) mean Ebg
as 2.20.4 nS and Ibg was 8.01.3 nS. The most obvi-
us effect of a reduction of Mg2to 1.0 mM was a doubling
f Ibg with no effect on Ebg. At 0.5 mM Ibg was increased by
ver 500%, and now Ebg was also increased, but only by
round 50% of its control value. The biggest change in Ebg
ccurred on switching to 0 mM Mg2, when an increase of
ver 350% rapidly occurred. However, at this stage, Ibg
as also further increased by over 1000%. All told, the
elative changes in excitation and inhibition resulted in a
atio change from 3.80.3 to 21.88.5 in favour of inhibi-
ion. At 1.0 mM, two out of six neurones began to display
pontaneous slow wave oscillations as described by us
reviously (Cunningham et al., 2006). However, within 5–8
in of reducing Mg2 to zero, all neurones began display-
ng a brief interictal like events, which were rapidly followed
y development of long lasting (10’s of s to minutes) ictal-
ike events (Fig. 7B), precluding any further VmD esti-
ates. Immediately prior to the development of epilepti-
orm activity excitability increased with spike threshold fall-
ng from 22.31.3 to 16.20.9 mV, although surprisingly
he number of spikes evoked by a suprathreshold pulse
as unaltered.
4-AP. 4-AP has frequently been used as an acute
onvulsant in the entorhinal cortex (e.g. Barbarosie et al.,
000). We have tested its effects on background synaptic
onductances in six neurones. We tested both 20 and 40
M, but there appeared to be little difference so results
ere pooled. The results are summarized in Fig. 7C. As
ith lowered-Mg2, 4-AP resulted a substantial increase in
oth Ebg (from 1.70.2 to 3.50.5 nS; P0.05) and Ibg
6.10.8 versus 23.55.8 nS; P0.05). Overall, the
hanges were not as marked as with low-Mg2 and the I:E
atio was increased from 3.70.4 to 7.21.5. Again, VmD
stimates were made just prior to or after the first appear-
nce of epileptiform discharges. The latter were complex
nd variable and consisted of combination of brief interical
ike events and longer lasting ictal-like discharges as well
s spontaneous ectopic spikes, synchronized inhibitory
ischarges and combinations of these (Fig. 7D). At this
ime, intrinsic excitability appeared largely unaffected,
ith spike threshold at 23.41.0 mV compared to the
ontrol value of 21.81.9 mV and number of spikes on
suprathreshold pulse 4.80.2 compared to 5.50.2.
s with bicuculline and low-Mg2, the occurrence of
ecurrent spontaneous epileptiform activity made VmD
stimates almost impossible.
DISCUSSION
he traditional view of epileptogenesis is that it derives
rom a disrupted balance between neuronal inhibition and
xcitation, manifest at the intrinsic (membrane ion chan-
els) and/or synaptic level. A huge body of research has
ayered complex and interacting facets of ion channel be- eaviour and synaptic communication into this simplistic
oncept. Derivation of the complexity of intrinsic/synaptic
etwork changes associated with epileptogenesis has
een substantially informed by experimental investigation
f dysfunction of behaviour in the pathological condition,
nd by the determination of the pharmacological actions of
rugs used to treat it. Nevertheless, the basic tenet that
pileptogenesis is a consequence of excess excitation,
eficient inhibition, or a combination of the two, is still
idely accepted.
AED have been generally categorized as those that
rimarily aim to promote inhibition, reduce excitation, or
odify voltage gated ion channels. It is also the case that
dentified gene mutations, which are emerging from mo-
ecular genetic studies of epileptic syndromes, are begin-
ing to fall into similar broad categories (see Rogawski and
oscher, 2004). However, it is accepted that AED are
romiscuous in their actions, and most have multiple tar-
ets. In the current study, rather than focus on specific
olecular targets, we have attempted to determine
hether diverse drugs may elicit a generalized change in
etwork excitability that could underlie anticonvulsive ac-
ions. The approach we used was based on a method of
stimating global synaptic conductances from membrane
otential fluctuations arising as a result of spontaneous
ring and transmitter release in presynaptic inputs (Ru-
olph et al., 2004). It allows a simultaneous estimation of
he strength of background inhibition mediated by GABAAr
nd excitation mediated by AMPAr, independent of the
inetics or site of origin of the individual synaptic activities.
owever, while it allows us to integrate overall synaptic
esponses it does not allow us to distinguish between fast
nd slow inhibition mediated at somatic and dendritic sites
or example. These may have very different roles and
unction in epileptogenesis (e.g. Maglóczky and Freund,
005; Knopp et al., 2008). It also does not take account of
ackground conductances mediated by GABAB or NMDAr,
or example, but this is unlikely to be a problem since
either appears to contribute much to spontaneous activity
n the EC (e.g. Berretta and Jones, 1996; Bailey et al.,
004). Non-synaptic neuronal communication via gap-
unctions is also important in epilepsy (e.g. Traub et al.,
004; Nemani and Binder, 2005) and these are also not
ccounted for directly by VmD. Nevertheless, we have
reviously validated the use of this approach to estimate
hese conductances in EC neurones (Greenhill and Jones,
007a). Despite the limitations, the approach provides an
stimation of background inhibition and excitation (Ru-
olph et al., 2004), and our previous studies have shown
hat the background conductances are altered in a predict-
ble and explicable way by drugs with known pharmaco-
ogical actions (Greenhill and Jones, 2007a). Thus, we feel
onfident in applying the VmD approach to determining the
lobal effects of AED in the balance between inhibition and
xcitation in cortical networks.
The most striking observation from these studies is the
onsistent effect of all the AEDs studied in increasing
he I:E ratio in favour of I . This applied regardless of thebg
ffect of each drug on individual conductances. For exam-
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S. D. Greenhill and R. S. G. Jones / Neuroscience 167 (2010) 456–474470le, phenytoin and lamotrigine both increased Ibg and de-
reased Ebg, whereas gabapentin and felbamate decrease
bg with little effect on Ibg, and tiagabine increased both.
evertheless, in each case, I:E ratio was increased likely
eflecting an overall strengthening of inhibition over exci-
ation. There did appear to be quantitative differences in
he extent of the increased ratio. Perhaps unsurprisingly,
he biggest changes were seen with phenytoin and lam-
trigine, which induced changes in Ibg and Ebg in opposite
irections. However, the consistency of the effect among
he AED tested could well point to this as common mech-
nism underlying anticonvulsant effects.
The changes in background synaptic activity were ac-
ompanied by a reduction in cellular excitability, evidenced
y decreased spike threshold and depolarization induced
ring. Again, these changes were consistent among the
ED tested and it is tempting to link the excitability change
ith the relative increase in background inhibition. Increas-
ng evidence has suggested that spontaneous transmitter
elease and the resultant synaptic noise are an important
eterminant of neuronal excitability (Pare et al., 1998;
tevens and Zador, 1998; Destexhe and Pare, 1999; Ho
nd Destexhe, 2000; Rudolph and Destexhe, 2001; Stacey
nd Durand, 2000; Fellous et al., 2003; Shu et al., 2003a)
o it is conceivable that the decline in excitability may be
ssociated with the overall increase in synaptic inhibition.
owever, we have no direct evidence that this is the case
t present, and the link remains circumstantial.
We also studied several drugs that might not be ex-
ected to exert anticonvulsant effects. Glutamate uptake
ppears to be compromised in a number of models of
pilepsy (e.g. Gorter et al., 2002; Campbell and Hablitz,
008), mice lacking glutamate transporters display an ep-
leptic phenotype (e.g. Tanaka et al., 1997), and in some
pilepsies, mutations encoding genes for glutamate trans-
orters may predispose towards epilepsy (e.g. de Vries et
l., 2009). Thus, blocking glutamate uptake might be pre-
icted to have proconvulsant effects. In whole cell patch
lamp recordings the glutamate uptake blocker, PDC, in-
reased the frequency of sEPSCs and slightly prolonged
heir decay times, but was without effect on amplitude. It
lso increased the frequency of sIPSCs, and caused a
on-significant increase in amplitude without effect on de-
ay times. These effects are partly due to increased ac-
ess of released glutamate to presynaptic kainate recep-
ors on excitatory terminals and both terminals and soma/
endrites of inhibitory neurones (Chamberlain and Jones,
npublished observations). Overall, these changes re-
ulted in an increase in total charge transfer associated
ith both spontaneous glutamate and GABA release, and
hese changes were mirrored in VmD studies. Thus, al-
hough PDC increased Ebg it also promoted Ibg, with the
esult that there was no change in I:E ratio. Significantly,
DC also failed to change neuronal excitability, further
upporting the possibility that excitability and I:E ratio may
e linked.
There is considerable controversy over the role of
onoaminergic systems in epilepsy and, while there is aarge body of evidence to suggest antidepressants are eroconvulsant, there are also clear indications for anticon-
ulsant effects (see Jobe and Browning, 2005). Our stud-
es do not provide evidence to really support either view-
oint, since we found that the antidepressant drugs, fluox-
tine and desipramine, failed to alter either Ibg, Ebg, or
ntrinsic neuronal excitability. Finally, there is evidence to
uggest that the atypical antipsychotic, clozapine, may
ave proconvulsant effects (Wong and Delva, 2007). De-
pite evidence from studies in prefrontal cortex to suggest
hat clozapine can potentiate (Chen and Yang, 2002) or
nhibit excitation (Gao, 2007) and enhance inhibition (Gao,
007), in our studies, it failed to change any parameters
stimated in VmD experiments.
So overall, of those agents we have tested to date, only
rugs with unequivocal clinical anticonvulsant activity elic-
ted the increased I:E ratio and decreased neuronal excit-
bility. These effects occurred regardless of the known
olecular targets of the diverse agents. It is also clear that
he effects on global conductances correlated reasonably
ell with data on spontaneous glutamate and GABA re-
ease from whole-cell patch clamp recordings. We have
hown in previous experiments that AED alter release in
ifferent ways and by different mechanisms (Cunningham
nd Jones, 2000; Cunningham et al., 2000, 2003, 2004;
ang et al., 2007). We have extended these studies here,
nd some discussion is warranted.
Previously, we have shown that felbamate can de-
rease sEPSC frequency by blocking presynaptic facilita-
ory NMDA autoreceptors (Yang et al., 2007). In contrast,
lthough felbamate has been suggested to enhance GABA
urrents in cultured neurones (Kume et al., 1996; Rho et
l., 1997; Simeone et al., 2006) we have now shown that
he drug has little effect on sIPSCs at EC synapses, al-
hough it slightly, but non-significantly increased decay
ime. The lack of effect could be associated with a dem-
nstrated sub-unit specificity of felbamate at recombinant
ABAAr (Simeone et al., 2006). Thus, the patch clamp
tudies are in agreement with the lack of effect on Ibg.
Qualitatively, gabapentin resembled felbamate in its
ction. We reported earlier that gabapentin acts presynap-
ically to reduce the frequency of sEPSCs in EC neurones,
n effect due, at least partly, to reduced Ca-influx via
/Q-type VGCC (Cunningham et al., 2004). We show
ere, that gabapentin has little effect on frequency, ampli-
ude or kinetics of sIPSCs, again in agreement with our
mD studies. There is reasonable evidence that prolonged
pplication of gabapentin may enhance GABA levels and
urnover in some brain regions (see White et al., 2007), but
his is not reflected in our acute studies. In support of this,
akasu et al. (2008) found no effect of gabapentin on
IPSCs in rat locus coeruleus neurones under normal
onditions. Experiments in synaptosomes prepared from
uman neocortex showed a decrease in depolarization
nduced GABA release by gabapentin, but there was no
ffect on basal release (Brawek et al., 2009). Finally,
arker et al. (2004) showed that gabapentin reduced re-
ease of glutamate from rat neocortical slices, while having
o effect on GABA. They suggest that this is due to differ-
ntial activation of presynaptic GABAB auto and heterore-
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S. D. Greenhill and R. S. G. Jones / Neuroscience 167 (2010) 456–474 471eptors, but whatever the mechanism their results are in
xcellent concordance with ours from both patch clamp
nd VmD analysis.
Tiagabine had effects on both sIPSCs and sEPSCs
n whole cell patch clamp studies. The prolongation of
IPSCs presumably reflects the blockade of GABA uptake,
nd is similar to effects on sIPSCs reported in other areas
Williams et al., 1998; Chan and Yung, 1999, 2003). This
as accompanied by a decrease in frequency, which again
as been reported previously (Williams et al., 1998; Chan
nd Yung, 1999, 2003), and is likely to be mediated by
ctivation of presynaptic GABAB autoreceptors as a con-
equence of increased accumulation of GABA following
ptake blockade (Chan and Yung, 1999, 2003). In contrast
o these previous studies where amplitude was either un-
ltered (Williams et al., 1998), or reduced (Chan and Yung,
999, 2003), sIPSC amplitude was increased by tiagabine
t EC synapses. This could suggest that postsynaptic
ABAAr are not saturated during spontaneous release of
ABA at these synapses. In contrast to sIPSCs, the am-
litude and decay time of sEPSCs was not significantly
ffected by tiagabine, so it seems unlikely that the drug (at
he concentration tested) has an effect on glutamate up-
ake (cf PDC) at these synapses. However, tiagabine did
nduce a significant increase in frequency of sEPSCs. We
ave no ready explanation for this at present. Activation of
resynaptic GABAAr have been shown to enhance gluta-
ate release at terminals on neurones at a number of sites
Koga et al., 2005; Jang et al., 2006; Alle and Geiger,
007; Stell et al., 2007) so one possibility is that of spillover
f GABA to GABAAr on glutamate terminals occurs follow-
ng uptake blockade with tiagabine. Whatever the mecha-
isms involved, tiagabine clearly had complex effects on
ifferent parameters of both spontaneous glutamate and
ABA release. However, when we calculated total charge
ransfer associated with sEPSCs and sIPSCs, overall, both
ere increased by tiagabine, with a more dominant effect
n inhibition. Again, this is in good agreement with the
mD estimates, which suggest a doubling of I:E ratio and
ccompanying decline in cellular excitability.
Finally, given the consistency with which the AED al-
ered global background synaptic activity, we thought it
as worthwhile testing the effects of agents known to
rovoke acute synchronized epileptiform activity. The sim-
listic prediction would be that these might be expected to
rovoke opposite effects to AED. This appeared to be case
ith the GABAAr antagonist, bicuculline. Thus, Ibg was
ramatically reduced, as expected. At the same time, Ebg
as slightly increased, which we attribute to loss of net-
ork inhibition of the principal cells and increased recur-
ent excitation (Dhillon and Jones, 2000). When I:E ratio
pproached unity, neuronal excitability was increased and
pontaneous epileptiform activity was initiated.
The situation with the other convulsant treatments was
uch more complicated. Both strongly increased Ebg as
ight be predicted, but both also strongly increased Ibg
nd I:E ratio. The increase in inhibition is likely to be due to
strong enhancement of GABA release. We have previ-
usly shown that both inhibition and excitation are in- dreased during the development of epileptiform activity in
g-free medium (Jones, 1994). This could occur by a
umber of mechanisms. Lowering [Mg2]o is likely to re-
ove a physiological block of presynaptic VGCC leading
o increased release (Carbone et al., 1997). In addition, it
ill increase excitability of interneurones via reduced sur-
ace charge screening (see Mangan and Kapur, 2004).
nterneurones in the EC receive a very powerful network
rive mediated by NMDAr (Jones and Buhl, 1993) and this
hould be increased by removal of the Mg voltage-depen-
ent block of these receptors. GABA-release is also facil-
tated by presynaptic NMDAr (Woodhall et al., 2001), and
his effect would be increased by loss of the Mg-dependent
lock. Of course, all these considerations will also apply to
he glutamatergic principal cells.
4-AP could also be predicted to increase both excita-
ion and inhibition. Indeed, synchronized GABAergic po-
entials are a feature of 4-AP-induced epileptiform activity.
gain this would arise partly through increased release of
oth transmitters as a result of blockade of repolarizing
-currents in presynaptic terminals (Southan and Robert-
on, 2000; Qian and Noebels, 2005; Westphalen and
emmings, 2006). It is also likely to lead to increased
euronal excitability in some neuronal subtypes, with con-
equent further effects for network driven release. It is
learly the case that the network effects of 4-AP are ex-
remely complex with combinations of synchronized exci-
ation, inhibition and generation of ectopic spikes all evi-
ent during epileptiform activity (see also de Guzman et
l., 2004; Keros and Hablitz, 2005).
The mechanisms underlying synchronicity in the
ow-Mg and 4-AP models, therefore, do not fit simply with
he decreased I:E ratio model that is apparent with bicu-
ulline. In truth, this is not particularly surprising. The com-
lexity and multiplicity of effects of these treatments largely
recludes the simple approach afforded by the VmD
ethod. VmD measurements are limited to estimating the
lobal effects mediated by GABAAr and AMPAr. They do
ot take any account of background excitation mediated by
ither NMDAr or inhibition mediated by GABABr (Rudolph
t al., 2004) both of which are likely to occur during in-
reased release of transmitters induced by low-Mg or 4-AP
e.g. Jones, 1994). VmD does not take account, either, of
ltered intrinsic membrane conductances (Rudolph et al.,
004).
It should also be noted that the activity elicited by any
f these treatments is not true epileptic activity in any case,
ut an artificial provocation of synchronization; the term
pileptiform is used advisedly. The disruption of normal
unction is induced by multiple changes in both synaptic
nd intrinsic properties of neurones interacting across the
hole network. The very different forms of discharge
voked by the three convulsant treatments are testament
o different underlying processes. Whilst the effects of
hese convulsants may not realistically reflect the changes
ssociated with true pathological epilepsies, at the same
ime it is unlikely that a simple imbalance in inhibition and
xcitation is the pathological cause of epilepsy, and indeed
ifferent epilepsies will certainly have different underlying
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S. D. Greenhill and R. S. G. Jones / Neuroscience 167 (2010) 456–474472athological causes. It is tempting to suggest that our
esults indicate that AED reduce seizures in a “symptom-
tic” way without targeting specific core deficits in network
unction. In this scenario, drug-resistance could involve
ore deficits that would not be ameliorated by a simple shift
n I:E balance, or were not dependent on such a change.
o date we have only assessed the effects of the AEDs
gainst “normal” network function, so now there is a need
o expand these studies to determine if VmD can be of
alue in assessing changes in network function in chronic
pileptic tissue (e.g. from kindled rats or pilocarpine/kai-
ate models), and whether the effects of the AED may
iffer in this situation.
CONCLUSION
hus, in summary, we have found that a common effect of
ED is to elicit a shift in the ratio of global inhibition to
lobal excitation in favour of the former, regardless of the
hange in the individual conductances. This shift occurs
oncurrently with a decline in intrinsic neuronal excitability,
lthough any link between the two is circumstantial at
resent. Nevertheless, it may be that the specific molecu-
ar targets of individual drugs are less important than the
bility to globally shift neuronal and network excitability to
more stable configuration. To date, we have only re-
orded these effects in normal tissue, and the situation
ay differ in the chronic epileptic condition. Of course, in
he chronic condition, there are will be alterations to net-
ork activity per se. What we need to do now is examine
he effects of the AED on global conductances in the
yperexcitable state that characterizes the pathological
ondition, to determine if the alterations in I:E ratio are still
vident, and correlated with amelioration of synchronized
ischarges.
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